Hepatitis C, Chronic  >>  IDX 184  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
IDX 184 / Merck (MSD)
NCT01157104: A Drug-Drug Interaction Study Evaluating the Combination of IDX320 and IDX184 in Healthy Participants (MK-6844-002)

Completed
1
20
US
IDX320, IDX184, IDX184 placebo, IDX320 placebo
Merck Sharp & Dohme LLC
Chronic Hepatitis C
07/10
08/10

Download Options